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SUMMARY 
The infiuence of donor major histOCompatibility complex (MHC) class 1· or class ll-deficie:n.cy on 
the: initiation of 1iT$t- and second-set ro;icc:tion of mOU$o heart IlDd liver ullografts wa$ examined. 
C3H (H-2") mice received heterotopic cardi.a.c or orthotopic livor grufta ffom WUIlodified B10 (H-
2b), B6 Ee-O~K b2m (H-2·; class 1 deficient) or ABo (H.Zb; class U deficient) donors. Organ survival 
was also investigafed in C3H recipients that had been presensiti2ed by a normal B I 0 skin graft 2-3 
weeks Wore heart Or liver tIaospiantation. The absenc;c of cell surface MHC dass I or class II 
rosultcd in significant prolOllgatioll (If priwa.ry cardlm: allograft survival. Three of se1feTl (43%) 
MHC class 1-deiicient, and two of five (40%) class ll-dc:1icient hean grafts were accepted 
indefinitely (survival time> roo days). Thus both MHC clasa 1 and cla.ss H molecules appear to be 
important for the elicitation of first-set rejeotiOD in the beart allograft m<xlcl. All livec aUografts 
sur\'ived > 100 days in normal recipients. In ClH recipients that had. been presenaitlzed by It BIO 
skin graft. however, both heart and liver grafts from ABo (class U 4eficicnt) donors Ilndcnvent 
acc¢lera~d rejection (median survival time [MSIJ 3 and 4 days, respectively). In colltIaSt, liver 
grates from class I-deticimt mice (b2m) were stiR accepted indc1initely by BI0 skin-presensilized 
C3H recipients, whel'Ql.$ class I-dedlcicnt haulS survived signi1l.cant1y lODzcr than those from class 
U-deficie:nt Of normal donors. The3C data demonstrate that the expression of donor MHC class I, 
and not class II is crucial in initiating second-set organ allograft rcjo;tioD. In vilTO monitoring 
revealed that at the time: of organ trallSplant. both sp1enocytc:tl $nd serum of UlC akin-prescn&i ti7,Cd 
animal$ displayed high cytotoxicity against ABO (class n.deficlel1t) but not agajQst b2m (claas J-
deticient) targets. 
INTRODUCTION 
Major histocompatibility complex (MHC) antigens eltpxt$S¢d 
on alloerafted tissue are consideted to be the main stimuli 
inducing r~ectionK The role of MHC class I and class II 
antigens in the Survival of vascularized allografts both in mice 
and ratl! b.u been studied using congenic aDd recombinant 
stral~ of Cl\perimental aDimals.I -6 The results however. have 
been colltrover.sicl, mainly "'-"Cause of the poor compatibility of' 
tho donor and recipient ::ttains. In addition., the immuno-
modulatory function of solubl<; MHC class 1 protein:!. h!1.3 been 
u.ucertain.'·· The recent availability of tn.n'se-nic: ('knockout') 
mice that Clo not express cell surface MHC cla$s 1,,10 or class n 
Rctcived 27 September 1995; revilled 16 December 1!l9S; acc:cpte<l 
17 ~ber 1995. 
Abbrcvi:ltiom: ABo. C57BL/6J.ABo; B6. C57BL/61; 'BIO. eSTBLI 
IOJ; b2m. CS7BL/6J-b2m"IV",,; CML. ~e1f·mediatcd lymphoeytotoXi-
city! !nAb, monoclonal antibody; MHC, major hiatocompatibility 
complex: MLR. mixed Iymphocyrc rcac:tio!l; MST, median survival 
time. 
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mOlec:Ulesll provides the opportUnity to delineate more clearly 
the roles of these MHC JeDe products in tmnsplant responses, 
without c;hangiDg the donor-recipient Strain combination. I :t-14 
Several studies have shown that $kill grafts ftom MHC class f~ 
or cla$$ II-deficient xci¢(; arc rejected as tapidly as normal skin 
both DY MHC-dispar.ue hQ:jta and by MHC-idc:ntic:al recipiCQts 
dift'erlng only at .IlO1l-MHC-loci. I}-IS The telXlpO of immune 
responses to nonKvascu~arl%ld skin grafts how~rK is frequently 
dift'erent from Illat to vascularized organ allogIafis. In tbe 
~t :study therefore, we have c:wnined the influence of 
donor MHC class I-or class II deficiency on first. and $C)Cond-
(jet !ejection of moase vascularized heart and liver tI3nsplanu. 
MATERIALS AND METHODS 
Mlcll 
Normal male mice of the CS7BL/IOI (B10; eKO~I C57BL/6J 
(B6; H-2" C3H/HeJ ECge;e-O~ a.rui BALB/cByl (BALBI 
c:H-Z") strains and MHC-ddicient lXlale auimals were pur-
chased from The Jackson Laboratory (Bar Harbor. ME). 
MHC class I-defieient C57HL/6J-b2m""IV40 (b2m! H-2") mice 
ate d6ficient in the expression of ceU surface MHC class I 
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2CDC. MHC class fl~1ieient mice CS1BL/6J.ABo (A.Bo; H-2">, 
contaln a <li$tupted A'bJJ icne :necessary to form c;ell surface 
class II molecules. The mice were maintalned In the speciJic 
pathOgCJl-fRO facilily of the UDiveJ3ty of Pittsburgh Medical 
Center, provided wit.h Purina rodmt chow and tap water ad 
/ihilwn. and used at lO-12-wem of ase. 
SUI'gical Proccr.lW'es 
All operations were performed under inhalation mcsthesia 
usme methoxyfturane (pitman-Moore, Atlanta,. GA). Hetero-
topic cardiac transplantation LO Qn abdominal site was 
pcIformod as described previouslyKD~ The function of tho 
heart WI13 monitored daily after transplantation byabdomlnal 
palpation. '("otal ceNation of c;ontractiQn wa& dcfulcd a6 
rejeotion. Orthotopic Rver trIWIplanta.tloD, in which revascWar-
izatioD was with a combination of Buture and cuff teclmiquea, 
was pcrfonned as tkscribed in detail c1scwberc:.17 1bc hepatic 
artery was not reconstructed. To examine secoDdafd: rejection. 
a fun thickness skin £raft (8 mm2) from the donor (BIO) tail was 
plao:d on the dorsal side of the recipient trunk. 2 to 3 weeks 
before whole-organ tmnspJantatlon; as described previoualy.J8 
Mixd lymphtJcylt D~aclwn (MLR) 
Equal numbers (2 x 1 l~ (well) of naponcier and ,),-inadiated 
(200y) stimulator splonooytc:s \VCR suspImdul in RPMl-l640 
(Gibco, Grand Island, NY) supplcmcntccl with 10% v/v neat-
iDa.ctivatod tbUll calf serum (FCS). 2W( JrglutamiDc. 0-1 DIM 
noo-essential amino acids. 111)M sodium pyruvate, , X lO-sM 
2-metcaptoethanol. lOOU/lnl penicillin. lOOmg/ml strepto-
mycin, IUld IJml HBPBS (Gibco). Aliquots (200111) were 
placed in triplicate, in U·bottomed 96-wc11 microculture plata 
(Coming, Coming, NY). The cultures were maintained for 
96br at 3'1" in S% COol in air. Each well was pulsed with 1 JlCi 
rmrdR (NEN. Boston. MA) 18hr before termination of the 
asay. The cultures were harvested onto gIaa fibre 1Ilters 
(Wallace Oy, Twku, Finland) and thymidine uptake was 
mta:Surod in " Bolaplal.o'I'M 120S liquid :MlllilhW.on WUIlI.« 
(pharmacia LICB, Ga.itherahurg. MD). R.esults are ~ as 
the mean c.p.m. ::I: ISO. Controls iDcluded responder or ..,.. 
irradiated stimulator cells incubated alone IUld n:spondcr a:Jls 
incubated with 'V-ilTllcliateci synJeIleic stimulators. 
Cel[Km~dialrd fymphucYUJlOxicity (CML) asmy 
Freshly iaoJated splccD cells obtained from ClH mice 
praellsitized with B10 skiD (2 weeks WON the test) woro 
used as efi'ectora. Splmocytes from BI0. B6, b.2m or AJJO mice 
cultured for 48hr in RPMI.l640 supplemented with S-IOpgJ 
ml Concanavalin A (Con A; SiSma. SL Louis. MO) were used 
as tatgetKK~ COn A·activated BALB/c ~pleen cell targets were 
used. as tblrd-pany controls. The target cc1Js were labelled with 
100 Ita ka~ Sler 0 4 (NEN), washed. and plated at Ii 
concentration of 4 x 10l cens/well in 96-well culture pla.= 
(Coming). Scrlal, twofold dillltioXlS of cKoctor cells wore IoIddocI. 
to givo effeclOr: target (E:T) fatio~ of 100: I, SO: 1 and 25: I in a 
tOtal volume of 2001'1fWell. The percentage of specific SICr 
release was determined after Incubating the plates for 4 hr at 37· 
in 10,". COl In !lir. An aliquot (IOO/lI) of lIupematant wu 
recovered from each well after centrifugation at SOO I for 1 miD. 
Maximum !ller relnse was deteImirwd by osmocto lysis of tile 
ocilllI. TM percc.utago-specific c:ytOtoxieity 'WaS calculated uing 
tho following formula: 
~ 1~S Blackwell Scienc:e Ltd.lt111nU11dogj. 88. 124-129 
% cytotoxicity -
~enta1 (e.p.m.) - spontanen~ (c.p.m.) 00 
mum (c.p.m.) _ Spontaneous (c. p.m.) x 1 
The nlSUll$ wo Cltpn:sliCd as means ± ISO or pereenta&c-
specmc SlCr rel0as0m. t.rip]iQu.tc cuJ.tumI. 
Conr,JIII'MIft-dt:pentknt cyrolyrlc tmlibfl(/y 1U1ivity 
Senam samples from nomW (control) and BI0 skin-scnsitizccl 
ClH mice (2 weeki after skin grafting) w= incubated. at W 
for 30min to inactivate complemont. Thtreafter. they weft 
CIilulCd serially in 96-well microtitre pI.ares (Corning) in Hank's 
balanced salt solutIon (HllSS) cootalnlng ()oJ"!. w/v bovine 
serum albumin (Slgma). Spleaic target c:eDs (5 x lOS) from 
OR, Bl0, 86. b2m, ABo, or BALB/c: mice were ad4c<l to caw. 
won and \.he pl&lw inoubatocl for 1 hr at room. temperature. The 
oell$ WOIO then W8lIhocllwicc in HBSS and 100 pi of baby rabbit 
comp]emeIlt (CedarlaJlc. Hornby, Ontario, Canada) wu added 
to each \II6ll. The plates WfI'e Ibm i1lCUbat£d for 30 miD at 37" iu $f"" COa in air. washed twiec with HBSS and incubated for an 
adctitiona13hr in lOOml HBSS supplemented with 10% PCS 
aud 20 pi 3-[4,5-Dimethylthiazol.2-ylJ-3, S-diphenylfonnazan 
(MTl'; SiJIDA). At the c:nd of the incubation period., tho cell. 
wcro wuhod twiilo tmd 1501'1 dimethyl sulfoxide (Sipa) was 
addod to tach woIL MIT folD1ll.2KJ1 wtIS dl.asolvcd by shaldDS 
tba plate vigorously, foU01II1Od by <=llifugatiOl1 at 11801' for 
1 min. Optical density waK~ measured at S50nm using a kinetic 
microplate reader (Molecular Dev1cea,. Menlo Park, CA). 
Controb mcIudcd bJauk. wells iUld target cells alone. 
Slotbtlc.r 
Median gtaft $UIVi'Y8l times between ~ of transplanted 
axUmals ~ comp8Rd usins the KroU.al-Wa1Jis test. a non-
parametriC eqUivalent to the ODO-wayanaly9is of variance. Pair-
• ~~ pcrfOIJDl:d by the MaIm-Whitney U· 
test. A BonfenolJi c:otreCtion was used to adjust the ovenll 
sisnJflcance ofo-OS by a factor of 1/3. Based on this correotioo.. 
.Pvalue < 0·02 for the paJr-wiMJ comparisons WD3 c:on.1idered 
sipifiQl.Dt. 
RESULTS 
'(Jae iducnee of MH.C cr_). or dass 11-4ldlcie8cy OD b- aad 
1IetCIDd..t rejcc:ticm of heart .... liver allot .... 
The sunival tim .. of orpn allografts from normal or MHC 
deftcieDt donor. in UlImodified hosta are shown in Table 1. 
Nonnal BIO or B6 heart srafts were rejected acutely by 
\lnmodified OK mipienbl within 1-1Z days (MST 8'S and 
11 days, respcclivoly). The survival otheans {com MaC class J-
deficieDt (b2m) or class ll-defideDt EAB~ lDice. however, was 
prolonged significantly (MST '0 and 4Ocla.ys, respective.,). 
Three of seven (43%) oC the cialll-deiciCDt, and two of five 
(40%) of clast Il-<l«fioient heart paCts wen 14lCCp~ ind.e&-
itdy ($lJ%Vival > 100 days) (Table 1). ~ te$U11$ indicale tbat 
cetJ Aurl~ upreMion both of MHC class 1 and class 11 is 
Important In the initiation offim-aet heart allograft rejection. 
As rcpone4 previously, l' no.ona.l BIO and B6 liver gra& wen 
accepted spontaneously ill umnodified C3H m:ipie:D.ta. With 
o_uce:ptlo.o.. ell aca.tU sunivecl '> l004ays. Not ''''P'WDalY. 
aU liver grafts from class 1- or class Jl-defi.cient mice aJso 
sunivec1 inddnitoly jn uormal ClH redpieots (Table 1). 
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MHC. Jlon-MHC HA 
MHC 
7,7..1. ]0, 10, m (CoS] 
n, U, 11, 12, 12 [1IJ 
> 100., > 100, > 100. > 10() I > 100J 
58, :> 100. > 100, > 100 [:> 1001 
II 
1 
19.20,22.30. "> 100, > 100. > 100 (30) 
25. PMK~I ;;> 100, > 100 (401 
:> 100. :- 100. ;;. 100, :;> 100 P'IOO) 
:> 100. > 100, > tOO. > 100 r > 1(0) 
* MST, lnedian surviYlll time (dll)'3). 
tMHCclatsl d~ftnenlK 
+ MHC Qa$S. II ck&icut. 
In presensitimi C3H (H-i') mice, all normal (BJO and BE) 
and almost al1 (5/6) class Il-<kficimt allografts (heart and liver) 
underwent accelerated acute rejection (Table 2). 'l'ile turvival 
of <llass l-dcftcicnt hearts in pR.'Imsitized Rdpionts, however, 
was prolonged a.igniflCl.lltly (P <: 0-01) wmpared with Uta, of 
hearts fl'om normal or class II-dc:fioient (ABO) mice. AllUm 
grafts from cia" I knockout donors (b2m) were acetpted 
indefinitely by prcsensiti1.e<i recipjeDts. In contrast, the MST of 
livers from class lI-defieient mice was only 5 day .. althaugh ane 
grlttl Curvi~ > 100 days. These data demonstrate the 
importance; of dODQ[ M1:lC cla$S I, but not class U expression 
ill initilltiog p<lClfki~sct heart and liYa: alIOgtaft rejection. 
mzofil~ve ltspOD&eS o( .pleaoeyte8 from slftl-~ 
ncipieats to cIoacw MHC dass I CIl' datf II uti~ 
Four-da.y Ml..R rt3pOnse5 ornonnal and 810 £kin-prcsensitbed 
C3H mice to C3H. BI0, b2m (class I ddicient). ABO (c.la:ss 11 
deftoient) Or BALB/e (third party) cells are shown in Table 3. 
Nuked increa&ea (5-8-(010) i.D. DNA f)'llthcsis ~ obGerved 
compared with contro)1; (stimulated with 9}'Dgme.iD or third-
party cells) wilen spJenocytCC from normal or pl'eIODSitizod 
C3H mice were cultured with ,.-ixradiated BI0 cell •• Ai 
expocted, because MLR responses s.re known to be cluJ U 
restricted. DNA synthesis by spleen cells from normal C3H 
Inigo in rcsponao 10 b2m (cbm 1 d~lF stimulators was 
signifioantly higher than that to ABo (CWJ II deficient) (lOlls.. 
However. tho MLR rnpODBIS of 0611, from skin-HMitir.ccl OH 
mice to class. I-deficlent stimulators (b2m). although higlw 
tban I'l:Sl'on5d to syngeneic cel),. did not d11[or statistically 
from tb.oae to MHC elass II-deficient EAU~ b1>loen cell&. 
Although dctrltmined at only OM time poinL (day 4), these 
MLR data s~t that the pro6ferative responses of pre.-
sensitized spleen cells are Dot clu. II ~tricbld in Ihe awe WilY 
as primu), T-ceJJ responses. The iubility, however. of 1/1 .,itro 
aSSlYs such as the MLR to adequarely reflect the In ,'IWJ 
imJnwologic status of aUognift recipients has been obterved 
previously both in humaoslO.2.1 and in mloo.!I'-.2' 
c ........ ted Iymphocytotoxicie, 
Fmhly isolated splenic e8'ector oe1Is troUl C3H mice sensitil.ed 
2-weoks previously with BI0 $kin -re UIIted for O)'I.o&oalc 
activity apimt Coo A~prlmed B 10, b2m. AB(l and 8ALB/c 
raqct cd1s (Tablc= 4). Cytolytic act1vlty a~ 10 be dinICt.ed 
apjnst donor class I antigms, since It. Itimiiar doaroo of 
cytotoxicity waa mediated. agaiD8t AJf> (GlU3 II deficient) (;dIs 
as against BIO cell, aud DO specifi.c killins \vus observed 1C~1lgD 
b2m (class I deficient) taraels. The aoceJtrated rejec:tion of BIO 
and. ABO liver and he4rt allogr.uts ob3erved ill 810 .kio-
seoa:iu= C3H m;ipients may therefore be explained, at teast in 
part, by the generation of donor MHC clllS3 J-dependent 
cyrotoxie T cell" The saults further Urgg~t thal the prolonpd 
,1Il"Vi'llal of Bver and hom allogralb rrom 1)2m m\lllult (cu 1 
deficient) mice in BI0 pnlll8l1SiUzed C3Ji recipients may be 
beCause of impaimlent of cytot~lc T -Qell developnlCtlt. 
(.)toJytic in~ MtMty 
Sera. obtained from C3H mice ~aitimi 2 week:! previoUily by 
TUJe Z. Organ a11o~ aurviVai ill C3R mice praetlsidzed to BJO skin 
Organ oOtlor Loci ClCPrCSlltd 




• MST, mcd.iaa sunlval tim. (dcly.). 
Gran 3IlrviVa1 (d.,,> [MST*] 
J, 4, 4. 5, 5 [4.1 
2, 3. 3. 3, ~ (3) 
'.7. 12, U, 20 [11t) 
2. 2, 3, 4., 4, 7 (H) 
4, 4. 5. S. 5 ($] 
3, 3. 4. 4. 4 (4-) 
,. 100, > 100.. > 100. "> 100 [> 100) 
4, s.. S, 5, > tOO {5] 
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Taf)(e 3.. Mixed lymphocyte reactivity ofspl~ ftQll1 DamW and pmensiti.?ed* OR ml~ 




3·07 ± 2'74 
4·07 ± 0·56 
810 b2m 




5-55:1: 0·48 3'OS ... Q'41 
13·17 J 1,02 6,91 = 2-21 
• B10 skin graClS were perfonul:d. 2 wccla before MLR tosting. 
t p < 0'01 COIXlparod with 1ho ~ of normal mice to Aa· celh. 





• 810 skiD graft& wen: performed 2 weeks bcfon: CTL Iestiog. 
BIO $1cin grattin2 exhibited. hIgh titres of lytic a.c;tjvity agam.,t 
B10. 86. and ABo (class 11 deficienl) spl~ cell ta.tgets (Fig. 1). 
Cytotoxic activity WIl$ maJdrnal or ncar JOalCimal up to 1:128 
SCl'UlD dilution. ~nd which it was reduced progre6uvely. In 
contrast, there was substantially lower cytotoxic antibody 
activity against b2m (cla$S I deficient) and third-party (BALBI 
c) targets. These data htdicate that prcsensiti?ed recipients arc 
able to generate spec:ifi.o complement-depenclent cytolytic 
antibodiOS onlY against donor MHC class I antigeDll, and not 
against clulS II anti~nsK They further $uggc:$t tbat the 








Figure 1. ComplcmCn~t l)'111.phoeytotoltio antibody tilrtl in 
sora from e3Y (H.Z") ~ tc:/\tiri7lOd by BIO (lJ.2") skin ~ 14 
ds)'5 p~nll~lyK Bl0 (8-2"). B6 (H-i'). b2m (B-2", dan I dc1i~ingtFK 
ABO Ee-O~K -oIasa II dt&ient), OH E~~F or BALB/c (H_2'lj third 
party) targets WUtl \tSQd. Results. are'melll valuer. obWncU fxom arou~ 
ofsixmicc. 
~ 1996 Btackwcll SciellCe Ltd. /.JtfmunolDgy, 18. 124-129 
graf\$ in Bl0 sfdn·pmcmi~ C3H mice may also bo due to 
Lbo cytolytic antibodies diroot.e<l against donor class I Il.ntigel2S. 
DISCUSSION 
MHC gene prociucts expressed on donor tissue arc believed to 
bo lbK~ JllQIccu1c:s principally 1'e:lpomibl£ for tho indyF~on of 
aUoimmuuity,24 and that serve u th<: targetS of the rejection 
respoDM:. 2S Althollgh the spccifio roles oCMHC clus I and class 
n mo1<OO\lle$ in various immune reactions have been subject of 
intensive investigation. much remains to be clarified. in this 
study. we used MHC class 1- or class II·dcficicmt mice as donors 
ofvascularlzed orean allogtafts to examine the contribution of 
these molccuh:$ 1.0 the initiatioD of first- and $CCOIld·sct 
rejection. The survival of primary hc:tcrotopic heart grafts 
from clau n-dcfk:icnt EAB~ or dass I-ddicient (b2m) mice Wal 
prolonged 3ipWioanUy in fuUy al1Knei~ OR recipients, 
compared with that of srafU from normal mice lIharing the 
same haplotype (810 ~r 86). Some of the beart g,rafta from 
either cla.ss 1- or claJs lI-defic.icnl <1onol'$ survived indcfilliteJ.y 
(> 100 days) (Table 1). These observations sugpt that both 
MHC c]as.., 1 and cia. II mol~ are important for finHet 
rcjecdon of v&scuJarizod cardi40 allografls, The in1luencc of 
d,'Dor MHC c;lIIlIs J or cws n dcficienQ)' on tirst-Nt hepatic 
alJograft Rjection could not be determined because in mice. 
transphmted liven ate a.c:cepted spontaneously.19 
It is v.Mil rccogni2ed that Udft n:jeCtion In recipients who 
haw nOl been exposed previously to trawJplantation antigens ia 
mediaU:d mainly by e:ffi:ctOI T o::ns. III 'conventional' immUlle 
tcspu,ll$C$, T lymphocytes recognize ColCilll Il.Iltigeus as 
procesllOd peptidoa presented in assoc:iation witb self.MHe 
mo.lecules on flntiU~Elresenting oen$,26 However, in alIo-
immune responses, T ccll9 can alkl recopize foreign MHC 
molcculos d.Irect1y as tnta.ct $buclure5 on the IUrface of the 
fOTCign <:ells.2.421.28 'IboK two pathways of T _U allol'COO"',.,nition 
axe refened to ~ 'inditcc:tt and 'direct' teflpectively. The 
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cootri&ution. of direa and inditect recognition to various 
etrector mecharrlsms (;f allo(!%*ft rojectiOIl remain UDC1ear. 
Further insipt is clearly important, ho",ever, as tbo two 
pal.hways an likely to have different requirements for activa-
tion lind to be regulated by distinot meobanisms. PrevlO'1JSlY.lt 
has ~n $uggested that in~ recogoitioll a(;QOUDb foc the: 
absence of delay in COjeotiOD of NBC class U-dcfieieut 8ldn 
pfts in a1Joseneic mice.",I:J The proloJ1ged sllrYival of heart 
grafts from c;Ws II-de6cieot donors iD Chis stuciy qpsts that 
dWect rather than indirect antilli'll presentation may be more 
important in the initiation of vascularized graft rejection than 
in the aculQ rePlioA of skiD allogcait$. 
Second ..... t aHosraft rejectiOQ is snedlatcd by compl", 
oollular and humoral meohanillU.'. We nporeed pmiously 
thaI presoositization with skin from class n-4etlcient, but no' 
Jiom class I-dc6cient mice, in4uce4 SUbtcqllCllt acodrmtecl 
rejectjon of both nortnlll bcatt and Ji1lef graftS.14 This latter 
findiDalndlcated that donor class I anlii.-ens were impoztaDt In 
host SCDIi tization.ln the present study, we oxamined tho role of 
donor olaas I and otaas n autigom in t~ initiation of tewnd-svt 
n;j~ion or orga,D grafts in =picnts pmcnsitizlc=d to I20rmaJ 
ano~cncic skin. C3H (B.zIC) miCllJ were prescnsitid with BI0 
(H-2, sltin then tt9ll~plaotA!ld with heart or liver grafts &om 
b2m (class l-cle:ficjeut) 0(' AIf (claM lI-deficient) donors 2-
wraa later (to allow for 'ful)' sensitization).lc AI expected. 
nomW B to and B6 heart anel Ii. gWls I.Uldcrwat 
acc:c1orated tejectJon in p.teSONitizc4 ~icn1UK A sbi\llar 
pattern of ac:ce1otatod ~ootion was observed m ~d 
recipients of.bean or liver JIaft- from AJt' (el_ n delc:ient) 
demors. In contrast. the IIlJ"VivaI ofliver srafts from b2m (class 
1 deficient) mice ",as not aJfecbld sigpificantly by BIO fkiD 
8eDsitization (Table 2), Class I-defic:ient heart 8l'IAs were 
however. rejed.ed earlier in $ensitlzed tban in llomJal rec:ipieDtis 
.Jthol.1gb the MST .... Ionpr thin in the three: othc:E' groups.. 
ThQSC results could be Cl(plaizac,d by tho tracoClCpreulOIl or .. 
J an&igoll&in tiKUreeo~miceKloqakeA tosetber bowt'llW, the 
data 'UII"t chat MHCdasJ I, mo~ than cI_1I antlgeu play 
It key role both In recipient sensitization and in the initiation or 
'second set' OIp11 allopaft Iejeotion. An implica.tioD of theM 
flndingdsthatavoidanccormiDimitatiooof<:IassImismatchos 
could &igoi1icandy reduce the potential for ~ rejection 
in ~tized organ allograft recipients. 
Tlw foar-day prolifen.tiw PlIIp0mc8 of spl8aocytcs ftom 
skin-pmemitiadmit:c: to b2m (class ldeficient) and ABO(dass 11 
deficient) cells did Dot di~ signibnUy. AclditloDal MLR rime 
pOInts (day 2 or day 3) would have been desil'llble to e1Jmfnace the 
possibility chat tbe kipetjc:s orthe two IaPQlJdingc:dl populatiaDI 
(sensitized and non«:nlidzed) 'Mn djft"aren1. In addition. it is 
CODCCi'Yablc that ~ teIpOnderI may react to stimulator 
allopeptidee (e.g. (rem cia .. 1 heavy chain Oltprcssed ~u-
1arly) ~~ OD aupcmder APe pteSeM itl the MLR cult\lnl$. 
Til vuro monitoring ~ that p~CalCytcc 04 semm 
from 8kin·prelOnSitizcd ..,Jma1s df&pla.yod higher cytOtoxicity 
againsl ABO (olass II deficient) than bam (0_1 dcfiGimt) GCll 
tuFtS. This suggoata that both cell- aDd aotif:lody-mediatod 
tMponIes account for second-set (acc:elerated) rejeotioa ofboth 
mouse hran and Iivet aUografts. It fUrilIe: appears that 
prcsensilized recipients ecnerate bath cytotoxic T ~11P and 
wmplement.dcpcndent qloCOAic alUibodlca speciftc to donor 
MHC elMS I but hot class n aDtiaens. It bu been observed dlat 
c1au I aatisens eJl:pressed on donor tissao serve All targets boIh 
fot c,totcOO.c T cella and ~otoFrc antibM4~ an p~uO*1 
hWlUbl allogmft recipiCDtL 29.JO Tho ~l fiAdJnp obtained 
usia, class I od dass n 'kaookoutt mico corrospond well with 
othu clInic:al data. Thus, a nqauve clue 1 c:omplomtmt-
depen&nt cytoto~ antibody croa.match has boon a pr~ 
reqvisite for rena) transplantation in muny (':Gtres.'l However. 
in vitw of our p~t findiDp, Iympbocyt&-mcdiatcd cyto-
toxicity leItillg may require further~Dsalllation as 11\1 additional 
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